Bank of Montreal
CRBP icon

Bank of Montreal’s Corbus Pharmaceuticals CRBP Stock Holding History

Bank of Montreal’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-598
Closed -$33K – 3826
2021
Q2 		$33K Buy
598
+529
+767% +$29.4K ﹤0.01% 3464
2021
Q1 		$4K Sell
69
-325
-82% -$21.4K ﹤0.01% 4711
2020
Q4 		$17K Buy
394
+278
+240% +$10.4K ﹤0.01% 4482
2020
Q3 		$4K Sell
116
-72
-38% -$13K ﹤0.01% 4490
2020
Q2 		$44K Sell
188
-178
-49% -$36K ﹤0.01% 3493
2020
Q1 		$53K Sell
366
-303
-45% -$51.2K ﹤0.01% 2870
2019
Q4 		$110K Sell
669
-2,471
-79% -$365K ﹤0.01% 3443
2019
Q3 		$458K Buy
3,140
+162
+5% +$28.2K ﹤0.01% 2462
2019
Q2 		$619K Buy
2,978
+2,309
+345% +$494K ﹤0.01% 2299
2019
Q1 		$139K Buy
669
+646
+2,809% +$142K ﹤0.01% 2914
2018
Q4 		$4K Buy
23
+12
+109% +$2.4K ﹤0.01% 4145
2018
Q3 		$3K Sell
11
-1
-8% -$162 ﹤0.01% 4222
2018
Q2 		$2K Buy
+12
New +$2.18K ﹤0.01% 4333
2016
Q2 		– Sell
-33
Closed -$2K – 4114
2016
Q1 		$2K Hold
33
– – ﹤0.01% 3963
2015
Q4 		$2K Hold
33
– – ﹤0.01% 3971
2015
Q3 		$2K Buy
+33
New +$2.2K ﹤0.01% 3789

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of Montreal's CRBP Position: Q3 2021 in Review

Bank of Montreal sold out of Corbus Pharmaceuticals (CRBP) in Q3 2021, closing a stake of 598 shares — an estimated $33K sold.

Bank of Montreal first reported a position in CRBP in Q3 2015 and held it in 16 quarters. The position peaked at $619K in Q2 2019. 85 funds tracked by Wall St. Rank hold CRBP as of Q3 2021.

  • Bank of Montreal reported no remaining Corbus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Bank of Montreal sold 598 Corbus Pharmaceuticals shares in Q3 2021, an estimated $33K.
  • Bank of Montreal first reported a position in Corbus Pharmaceuticals in Q3 2015 and held it in 16 quarters.
  • Bank of Montreal's Corbus Pharmaceuticals position peaked at $619K in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2021.

Based on Bank of Montreal's 13F filing for Q3 2021, filed 12 Nov 2021.